In vitro inhibition of lysine decarboxylase activity by organophosphate esters

Biochem Pharmacol. 2014 Dec 1;92(3):506-16. doi: 10.1016/j.bcp.2014.09.011. Epub 2014 Sep 28.

Abstract

Organophosphate esters (OPEs), a major group of organophosphorus flame retardants, are regarded as emerging environmental contaminants of health concern. Amino acid decarboxylases catalyze the conversion of amino acids into polyamines that are essential for cell proliferation, hypertrophy and tissue growth. In this paper, inhibitory effect of twelve OPEs with aromatic, alkyl or chlorinated alkyl substituents on the activity of lysine decarboxylase (LDC) was assessed quantitatively with an economic and label-free fluorescence sensor and cell assay. The sensor comprises a macrocyclic host (cucurbit[7]uril) and a fluorescent dye (acridine orange) reporter. The twelve OPEs were found to vary in their capacity to inhibit LDC activity. Alkyl group substituted OPEs had no inhibitory effect. By contrast, six OPEs substituted with aromatic or chlorinated alkyl groups inhibited LDC activity significantly with IC50 ranging from 1.32 μM to 9.07 μM. Among them, the inhibitory effect of tri-m-cresyl phosphate (TCrP) was even more effective as an inhibitor than guanosine 5'-diphosphate-3'-diphosphate (ppGpp) (1.60 μM), an LDC natural inhibitor in vivo. Moreover, at non-cytotoxic concentrations, these six OPEs showed perceptible inhibitory effects on LDC activity in PC12 living cells, and led to a marked loss in the cadaverine content. Molecular docking analysis of the LDC/OPE complexes revealed that different binding modes contribute to the difference in their inhibitory effect. Our finding suggested that LDC, as a new potential biological target of OPEs, might be implicated in toxicological and pathogenic mechanism of OPEs.

Keywords: Inhibition; Lysine decarboxylase; Molecular docking; Organophosphate esters; Toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cadaverine / metabolism
  • Carboxy-Lyases / antagonists & inhibitors*
  • Carboxy-Lyases / chemistry
  • Carboxy-Lyases / metabolism
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Esters / pharmacology
  • Fluorescence
  • Molecular Docking Simulation
  • Organophosphates / chemistry
  • Organophosphates / pharmacology*
  • PC12 Cells / drug effects
  • Rats
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Esters
  • Organophosphates
  • Carboxy-Lyases
  • lysine decarboxylase
  • Cadaverine